SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-094601
Filing Date
2009-04-30
Accepted
2009-04-30 16:55:55
Documents
5
Effectiveness Date
2009-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 38178
2 GRAPHIC g60243g08v07.jpg GRAPHIC 135326
3 GRAPHIC g60243g15j66.jpg GRAPHIC 215019
4 GRAPHIC g60243g53o07.jpg GRAPHIC 141498
5 GRAPHIC g60243g54v54.jpg GRAPHIC 181974
  Complete submission text file 0001193125-09-094601.txt   968746
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 09784671
SIC: 2835 In Vitro & In Vivo Diagnostic Substances